| Literature DB >> 26401848 |
Ingrid K Hals1, Simon Gustafson Bruerberg1, Zuheng Ma2, Hanne Scholz3, Anneli Björklund2, Valdemar Grill4.
Abstract
OBJECTIVE: To provide novel insights on mitochondrial respiEntities:
Mesh:
Substances:
Year: 2015 PMID: 26401848 PMCID: PMC4581632 DOI: 10.1371/journal.pone.0138558
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Reagents used in the different high-resolution respirometry protocols.
| Chemicals | Role | Protocol |
|---|---|---|
| Malate | Substrate, CI | N/A |
| Pyruvate | Substrate, CI | N/A |
| Glutamate | Substrate, CI | SUITCI, SUITCI+II |
| Succinate | Substrate, CII | SUITCII, SUITCI+II |
| Cytochrome | Substrate, CIV | SUITCI, SUITCII, SUITCI+II |
| ADP+Mg2+ | Substrate, CV | SUITCI, SUITCII, SUITCI+II |
| FCCP | Protonophore, uncoupler | ProtocolInt, SUITCI, SUITCII, SUITCI+II |
| Rotenone | Inhibitor, CI | ProtocolInt, SUITCI, SUITCII, SUITCI+II |
| Antimycin A | Inhibitor, CIII | ProtocolInt, SUITCI, SUITCII, SUITCI+II |
| Oligomycin | Inhibitor, CV | ProtocolInt |
| Digitonin | Permeabilization agent | SUITCI, SUITCII, SUITCI+II |
CI-CV: mitochondrial complexes I-V, ADP: adenosine diphosphate, FCCP: carbonyl cyanide-4-(trifluoromethoxy)phenylhydrazone, ProtocolInt: protocol for intact cells, SUIT: substrate-uncoupler-inhibitor-titration protocol for electron flow through CI, CII and convergent CI+II.
Fig 1Oxygraphic example output of protocols with intact and permeabilized INS-1 832/13 cells (at normoxia).
(A) Protocol with intact cells, (B) SUITCI protocol with permeabilized cells with glutamate as only reducing substrate, (C) SUITCII protocol with permeabilized cells with succinate as only reducing substrate, (D) SUITCI+II protocol with glutamate and succinate as reducing substrates. The blue line represents the oxygen concentration (nmol O2/mL) in the experimental chamber. The red line represents oxygen flux (pmol O2/s/106 cells), the negative time derivate calculated from the measured oxygen concentration, normalized to the number of cells. ROUTINE: ROUTINE respiratory state of basal respiration, LEAK: LEAK respiratory state of uncoupled respiration, OXPHOS: OXPHOS respiratory state of maximum phosphorylative capacity, ETS: ETS respiratory state of the maximum capacity of the ETS, ROX: ROX respiratory state of residual oxygen consumption, Dig: digitonin, G: glutamate, D: ADP, S: succinate, c: cytochrome c, F: FCCP, Rot: rotenone, Ama: antimycin A.
Definitions of the coupling control ratios (CCRs) used.
| Ratio | Definition |
|---|---|
| LEAK CCR | LEAK respiration normalized to ETS capacity (L/E). It expresses the portion of maximum respiratory capacity that is due to proton leak. It increases from a theoretical minimum of 0.0, fully coupled, to 1.0, fully uncoupled. |
| ROUTINE CCR | ROUTINE respiration normalized to ETS capacity (R/E). It expresses how close the ROUTINE respiration operates to the maximum capacity of the system. |
| Net ROUTINE CCR | ROUTINE respiration without the LEAK component, normalized to ETS capacity ((R-L)/E). |
| Phosphorylation system CCR | OXPHOS respiration normalized to ETS capacity (P/E). It expresses how close maximum oxidative phosphorylation approaches the capacity of the ETS. A value of < 1.0 signify control by the phosphorylation system on the OXPHOS capacity. Consequently, OXPHOS capacity is not limiting if P/E = 1.0. P/E > 1.0 is regarded as an experimental artefact. |
| Phosphorylation CCR | LEAK respiration normalized to OXPHOS respiration (L/P). It expresses the efficiency of the phosphorylation system, i.e. the amount of flux in OXPHOS respiration that is due to proton leak. |
L: LEAK state, E: ETS state, R: ROUTINE state, P: OXPHOS state.
Definitions of the substrate control ratios (SCRs) used.
| Ratio | Definition |
|---|---|
| Complex I Phosphorylation SCR | Complex I-linked OXPHOS respiration normalized to complex I + II-linked OXPHOS respiration (PCI/PCI+II). It expresses the portion of respiration in the OXPHOS state that is due to complex I-linked electron flow. |
| Complex II ETS SCR | Complex II-linked ETS capacity normalized to complex I + II-linked ETS capacity (ECII/ECI+II). It expresses the contribution of electron flow through complex II in the convergent ETS capacity state. |
PCI: phosphorylative capacity with electrons through complex I, PCI+II: phosphorylative capacity with convergent electron flow from both complex I and II, ECII: ETS capacity with electrons from complex II, ETSCI+II: ETS capacity with convergent electron flow from both complex I and II.
Fig 2Previous hypoxia (8 hours) increased basal but not stimulated insulin secretion in INS-1 832/13 cells.
Insulin release (final 60–90 min incubations) with 3.3, 11 and 27 mM glucose (G). Protein content was estimated from a mean of three measurements in each experiment. Data are mean ± SEM, n = 5, *P < 0.05.
Fig 3Previous hypoxia (8 hours) failed to affect levels of ATP in INS-1 832/13 cells.
Cells were cultured in RPMI with 11 mM glucose. Data are mean ± SEM based on five separate experiments (three parallels per experimental condition).
Fig 4Oxygen flux in different respiratory states in intact INS-1 832/13 cells.
Sequential respiratory states in the ProtocolInt protocol, comparing hypoxia with normoxia ROUTINE: basal respiration measured at physiological substrate conditions, before any reagent additions, LEAK: uncoupled respiration after addition of oligomycin, ETS: flux capacity of the electron transfer system, induced by FCCP, ROX: residual oxygen consumption, a measure of oxidative side reactions obtained by adding rotenone and antimycin A to inhibit complex I and II, respectively. Fluxes are expressed as means ± SEM of five experiments (comprising totally 12 single measurements),*P < 0.03.
Coupling control ratios (CCRs) derived from the protocol with intact cells.
| Coupling control ratio | Normoxia | Hypoxia | Definition |
|---|---|---|---|
| LEAK/ROUTINE ratio | 0.517 ± 0.040 | 0.537 ± 0.040 | L/R |
| ROUTINE control ratio | 0.493 ± 0.014 | 0.435 ± 0.024 | R/E |
| LEAK control ratio | 0.250 ± 0.022 | 0.230 ± 0.014 | L/E |
| Net ROUTINE control ratio | 0.239 ± 0.020 | 0.205 ± 0.024 | (R-L)/E |
L: LEAK state, E: ETS capacity, R: ROUTINE state. Ratios are means ± SEM of five experiments (comprising totally 12 single measurements)
*P < 0.05.
Fig 5Phosphorylative capacities of different NADH-linked substrate combinations.
The graph shows the ability of different substrate combinations of pyruvate (5 mM), glutamate (10 mM) and malate (0.5 mM) to stimulate respiration in the presence of ADP (2.5 mM). State 1 (eN) is used as a control state. No difference was found between state 1 respiration and the OXPHOS states of the different substrate conditions. eN: endogenous respiration without reducing substrates or ADP (six measurements), P: pyruvate (three measurements), GM: glutamate and malate (six measurements), PM: pyruvate and malate (three measurements), PMG: pyruvate, malate and glutamate (three measurements). Fluxes are expressed as means ± SEM.
Coupling and substrate control ratios derived from the SUIT protocols.
| Control ratio | Normoxia | Hypoxia |
|---|---|---|
|
| ||
|
| ||
| LCI/ECI | 0.418 ± 0.024 | 0.364 ± 0.030 |
| LCI/PCI | 0.448 ± 0.017 | 0.381 ± 0.018 |
| PCI/ECI | 0.918 ± 0.012 | 1.025 ± 0.024 |
|
| ||
| LCII/ECII | 0.264 ± 0.007 | 0.225 ± 0.005 |
| LCII/PCII | 0.265 ± 0.006 | 0.238 ± 0.006 |
| PCII/ECII | 0.982 ± 0.003 | 0.944 ± 0.019 |
|
| ||
| PCI+II/ECI+II | 0.968 ± 0.008 | 0.928 ± 0.019 |
|
| ||
| PCI/PCI+II | 0.160 ± 0.009 | 0.147 ± 0.002 |
| ECII/ECI+II | 0.687 ± 0.014 | 0.648 ± 0.006 |
CI: complex I, CII: complex II, L/E: LEAK control ratio, L/P: phosphorylation control ratio, P/E: phosphorylation system control ratio, PCI/PCI+II: substrate control ratio relating phosphorylative capacity through complex I with phosphorylative capacity by convergent electron flow, ECII/ECI+II: substrate control ratio relating maximum ETS capacity through complex II with capacity by convergent electron flow. Ratio are expressed as means ± SEM, based on four-eight measurements
*P < 0.05.
Fig 6Effects of hypoxia on mitochondrial complexes I and II.
Immunoblotting of subunits of the complexes were performed on cells and islets that were harvested after hypoxia followed by re-oxygenation (H) or continuous normoxia (N). Representative Western blots are shown.
Effect of hypoxia on mitochondrial complex protein levels.
| Amount of protein complex subunits I and II after hypoxia exposure(as % of protein levels at normoxia) | |||
|---|---|---|---|
| (n) | CI-NDUFB8 | CII-SDHB | |
| INS-1 832/13 | 4 | 130 ± 9 | 136 ± 10 |
| Rat islets | 8 | 134 ± 17 | 120 ± 9 |
| Human islets | 4 | 151 ± 13 | 176 ± 13 |
Complex (C) I and II subunits; NDUFB8: NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 8, SDHB: succinate dehydrogenase subunit B. Islets from eight rats and two human donors were used for the experiments. Data are means ± SEM
*P < 0.05 for the effect of hypoxia.